Browse Articles

Discover research articles across all indexed journals

Daily briefing: ‘Cyborg’ cockroaches breathe underwater with printed suit

Nature Jacob Smith Jul 02, 2026 DOI: 10.1038/d41586-026-02108-0

Fluid-mediated nuclearity control in heterogeneous polyolefin catalysis

Nature Communications Zaitian He, Jingyuan Sun, Qingyuan Zheng et al. Jul 02, 2026 DOI: 10.1038/s41467-026-75099-1

Protocol for the SACLA trial: Efficacy and safety of subretinal monteplase for submacular hemorrhage in a phase II single-arm multicenter decentralized clinical trial

PLoS ONE Noriko Yoshida, Yuko Kobayakawa, Kouta Funakoshi et al. Jul 02, 2026 DOI: 10.1371/journal.pone.0353127

Submacular hemorrhage (SMH), which may arise from age-related macular degeneration, retinal arterial macroaneurysm, and other causes, can result in severe vision loss and central visual field impairment. Although tissue plasminogen activator (tPA) is used off-label to treat SMH in many countries, no formulation has been approved for this indication. Because early intervention is critical when tPA is used for SMH, limited access to centers that can provide this treatment may delay care and reduce treatment opportunities. Decentralized clinical trials (DCTs) reduce or eliminate the need for participants to travel to trial sites. We therefore designed the investigator-initiated SACLA trial to evaluate subretinal tPA for SMH. The DCT framework is intended to reduce logistical barriers related to the disease severity and rarity. The SACLA trial is a phase II multicenter, open-label, single-arm surgical study with a pre-post comparison design (jRCT2071250003). Twenty eligible participants will undergo pars plana vitrectomy followed by subretinal injection of 0.1 mL (8,000 IU) of tPA. Participants will remain hospitalized at the trial site until the primary outcome, change in central foveal thickness (CFT) from baseline at Week 1, is assessed. Thereafter, follow-up visits will be conducted at either the trial site or partner sites within the DCT framework. Secondary efficacy outcomes include change in CFT from baseline, presence of a foveal hemorrhage measuring at least 1 disc diameter, best-corrected visual acuity (BCVA), and change in BCVA from baseline at Weeks 4 and 12. Adverse events will be collected throughout the 12-week observation period to assess safety. The protocol and related study documents were reviewed and approved by the Saga University Hospital Institutional Review Board. This study is designed to generate prospective evidence on the feasibility, short-term anatomical response, and safety of subretinal tPA for SMH.

Low- vs standard-dose regimens as induction for pediatric AML: a multicenter, randomized noninferiority trial

Blood Li Gao, Xiaowen Zhai, Ningling Wang et al. Jul 02, 2026 DOI: 10.1182/blood.2025030972

Abstract Intensive chemotherapy is standard for acute myeloid leukemia (AML) but carries high risks of life-threatening complications, particularly in vulnerable patients. We aimed to compare the efficacy and safety of a low-dose chemotherapy (LDC) regimen for induction of AML. A randomized, multicenter, noninferiority trial was conducted in patients with AML aged <18 years. Patients received low-dose cytarabine, mitoxantrone or idarubicin, and granulocyte colony-stimulating factor (G-CSF) or standard-dose chemotherapy (SDC; cytarabine, daunomycin, and etoposide). All patients received postremission consolidation with standard chemotherapy and/or hematopoietic stem cell transplantation. The primary end point was to compare response rates between treatments. The secondary end points were to compare the outcomes, toxicity, and safety of the LDC and SDC regimens. The 2 treatment arms showed no significant differences in outcomes. Complete remission (CR)/CR with incomplete count recovery rates after induction were 95.1% and 95.3% in the LDC and SDC arms, respectively. Measurable residual disease <0.1% after induction II was observed in 87.4% and 87.1% of patients in the LDC and SDC arms, respectively. Median time to neutrophil and platelet recovery was significantly shorter among patients receiving the LDC regimen. Patients in the LDC arm had a 4-year overall survival (OS) of 81.3% vs 83.6% (P = .611), and a 4-year event-free survival (EFS) of 61.5% vs 63.1% (P = .832). In conclusion, the LDC regimen was well tolerated, and was associated with CR, EFS, and OS rates that were not inferior to those of patients treated with the SDC regimen. The trial was registered at www.chictr.org.cn as ChiCTR1800015883.

Dynamic topology-aware multimodal hypergraph fusion network for load forecasting in novel power systems

Scientific Reports Xiaolong Lv, Qin Ma, Jie Du Jul 02, 2026 DOI: 10.1038/s41598-026-59612-6

Artificial intelligence shines a light on hidden global migration flows

Nature Francisco Lara-García, Van C. Tran Jul 02, 2026 DOI: 10.1038/d41586-026-01588-4

Intracellular assembly of artificial enzymes for cytoplasmic enantioselective Mannich reactions

Nature Communications Zhixi Zhu, Qinru Hu, Yao Wu et al. Jul 02, 2026 DOI: 10.1038/s41467-026-75059-9

Deep learning based two-way feature depiction model for brain tumor detection

PLoS ONE Shabana Urooj, Kiran Napte, Najah Alsubaie Jul 02, 2026 DOI: 10.1371/journal.pone.0344291

Brain tumors are one of the most fatal disorders that cause one of the highest mortalities in the world. Gliomas are the most common primary brain tumors originating from glial cells in the central nervous system. Traditionally, a tissue sample is extracted and examined for its genetic and characteristic properties. This method is invasive, painful, and takes a longer period to produce results. Various automatic Deep learning (DL) based schemes have been presented for the brain glioma detection, but they lack due to poor explainability, lower generalization, poor feature depiction, class imbalance problem and lower detection rate. This paper presents a deep learning based brain tumor detection using two way feature depiction model (TWFDM) that combines the 2D-Deep Convolution Neural Network (DCNN) and 1D-DCNN. The 2D-DCNN accepts the raw MRI images and the 1D-DCNN accepts the handcrafted local binary pattern (LBP), gray level cooccurrence matrix (GLCM), and Histogram of Oriented Gradient (HOG) features. Furthermore, improved particle swarm optimization (IPSO) is used for feature selection to minimize the computational complexity of the TWFDM system. The proposed TWFDM achieves an overall accuracy of 96.25%, a recall of 96.34%, a precision of 96.31%, and an F1-score of 96.32% on the Brain MRI dataset for four-class classification, representing an important improvement over traditional techniques.

Non-PF4/heparin-binding, platelet-activating antibodies in heparin-induced thrombocytopenia

Blood Lu Zhou, Andrew Cao, Wen Zhu et al. Jul 02, 2026 DOI: 10.1182/blood.2025032317

Abstract The hallmark of heparin-induced thrombocytopenia (HIT) is the presence of immunoglobulin G (IgG) antibodies against platelet factor 4/heparin (PF4/H) complexes, typically detected by PF4/H enzyme-linked immunosorbent assay (ELISA); thus, negative ELISA results are commonly used to exclude this diagnosis. Here, we report a prevalent yet previously unrecognized subset of antibodies that are undetectable by PF4/H ELISA (ELISA−) but activate platelets in the PF4-dependent P-selectin expression assay (PEA+). In 11 patients with clinically confirmed HIT who tested positive in both PF4/H ELISA and platelet activation assays, ELISA−PEA+ antibodies accounted for 65% ± 19% of total platelet-activating IgG activity and coexisted with ELISA+PEA+ antibodies. Consistent with this finding, single-cell cloning from 7 patients with HIT identified 23 PEA+ antibody-producing B-cell clones, of which 17 were ELISA−, outnumbering the ELISA+ clones. Functionally, ELISA−PEA+ antibodies closely resembled ELISA+PEA+ antibodies: platelet binding and activation required exogenous PF4 and were inhibited by FcγRIIA blockade, high-dose heparin, or Fab fragments made from ELISA+PEA+ antibodies. Importantly, these antibodies induced thrombocytopenia in a humanized mouse model of HIT. Despite lacking PF4/H reactivity in ELISAs, they recognize PF4 on platelets and showed no appreciable binding to neutrophil-activating peptide-2, interleukin-8, or PF4 alone. Structurally, these antibodies were heterogeneous, with a subset sharing heavy-chain features with ELISA+PEA+ antibodies. Collectively, our findings demonstrate that ELISA−PEA+ antibodies are a common, previously unrecognized feature of HIT, with functional relevance, supporting the possibility that they play an important, perhaps even central, role in HIT pathogenesis. Defining their prevalence, kinetics, and clinical impact deserves high priority for further investigation.

Trend and determinants of underweight among children aged under five years in Rwanda: secondary data analysis using Rwanda Demographic Health Surveys 2005–2020

Scientific Reports Gad Binayisa, Samuel Muhirwa, Imelda Dukuze Iryumugabe et al. Jul 02, 2026 DOI: 10.1038/s41598-026-59690-6

Electrodeposited self-assembled molecules for perovskite photovoltaics

Nature Zhihui Xiong, Xuanang Luo, Fushen Tang et al. Jul 02, 2026 DOI: 10.1038/s41586-026-10844-6

Ultra flash cold events under global warming

Nature Communications Yongli He, Zhanbo Wang, Xiaodan Guan et al. Jul 02, 2026 DOI: 10.1038/s41467-026-75094-6

Music-induced cortical plasticity: Protocol for a systematic review

PLoS ONE Isaiah Osei Duah Junior, Danielle S. Rodriguez, Cassandra M. Germain Jul 02, 2026 DOI: 10.1371/journal.pone.0336011

Music engages sensory, motor, cognitive, and emotional systems, making it a powerful model for studying experience-dependent neuroplasticity. Although research on music-related brain changes is expanding, integration of structural, functional, and cerebrovascular findings remains limited, and effects on higher-order cognitive processes remain unclear. This systematic review will primarily synthesize evidence on music-induced cortical adaptations, including structural changes (e.g., gray and white matter alterations), functional modifications in neural networks, and cerebrovascular dynamics. Further, associations with behavioral measures such as attentional control, executive functioning, and language processing will also be examined when these outcomes are directly linked to the neural adaptations across the adult lifespan (≥ 50 years). The protocol was prepared in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocols (PRISMA-P) guidelines and has been indexed in International Prospective Register of Systematic Reviews (PROSPERO ID: CRD420251159362). The systematic review will be conducted and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Using controlled vocabularies and medical subject headings (MeSH), a systematic search will be conducted across PubMed, Scopus, Web of Science, PsycINFO, EMBASE, CENTRAL (Cochrane Central Register of Controlled Trials), and Google Scholar databases, and supplemented by citation tracking from relevant review articles. Eligible studies will include randomized controlled trials (RCTs), non-randomized controlled trials, quasi-experimental, and observational designs (longitudinal, case-control, cross-sectional studies). The primary outcome will be changes in brain structure, function, and cerebrovascular hemodynamic activity following music intervention. Cognitive measures will be reviewed and consolidated as secondary endpoints. Data extraction, risk of bias and quality assessment will be performed independently by two reviewers using validated instruments, including Cochrane Risk of Bias 2 (RoB 2.0), Risk Of Bias In Non-randomized Studies – of Interventions (ROBINS-I), Risk Of Bias In Non-randomized Studies of Exposures (ROBINS-E), Strengthening the Reporting of Observational Studies in Epidemiology (STROBE), and National Heart, Lung, and Blood Institute (NHLBI) tools. A narrative synthesis will be conducted in accordance with Synthesis Without Meta-analysis (SWiM) guidelines, with meta-analyses undertaken where appropriate. Certainty of evidence will be assessed using Grading of Recommendations Assessment, Development, and Evaluation (GRADE) scale. Collectively, this protocol establishes a rigorous framework to systematically evaluate how music shapes the brain’s structure, function, and vascular systems, and how these changes translate into cognitive and behavioral outcomes.

Identifying steroid-refractory aGVHD before it happens

Blood Daniel Teschner Jul 02, 2026 DOI: 10.1182/blood.2026034423

Work autonomy mediates associations between medical AI readiness and well being in a three wave nurse study

Scientific Reports Mei Xie, Junming Xu, Yuexiang Liu et al. Jul 02, 2026 DOI: 10.1038/s41598-026-58212-8

VPS13C/PARK23 initiates lipid transfer and membrane remodeling for efficient lysosomal repair

Nature Communications Oluwatobi Andrew Adeosun, Christian Schröer, Elisabeth Südhoff et al. Jul 02, 2026 DOI: 10.1038/s41467-026-75145-y

Abstract Perturbations in lysosome integrity are tightly linked to neurological disorders and ageing, but the underlying pathogenic mechanisms are incompletely understood. Using an unbiased proteomic approach, we here identified the bridge-like lipid transport protein VPS13C/PARK23 as a key component of a global early response pathway to lysosome damage. VPS13C readily binds lysosomes under mechanical or osmotic tension in anticipation of membrane lesions. The latter trigger a conformational change in the protein’s C -terminus, involving its ATG2C domain acting as sensor of damage-induced lipid packing defects. We show that ER-lysosome contacts formed by VPS13C provide critical binding platforms for OSBP/ORPs to enable efficient ER wrapping of damaged lysosomes. A chemical approach to assess directional ER-to-lysosome lipid transport revealed that VPS13C is essential for large-scale lipid delivery to acutely damaged lysosomes to facilitate their repair. Our findings offer new mechanistic insights into how loss-of-function mutations in VPS13C may enhance the risk of Parkinson’s disease.

Calculation method and predictive analysis of flexural capacity of reinforced concrete beams strengthened with carbon fiber-reinforced polymer sheets applied to the side surfaces

PLoS ONE Xiang Liu Jul 02, 2026 DOI: 10.1371/journal.pone.0353001

In response to the situation where it is not allowed to stick CFRP cloth at the bottom of a concrete beam and stick it on both sides of the beam, this article analyzes the factors that affect the ultimate flexural bearing capacity of reinforced concrete beams reinforced with CFRP on the side, and provides a calculation method for the flexural bearing capacity of reinforced concrete beams reinforced with CFRP on the side; At the same time, for the convenience of calculation, this paper explores the comprehensive consideration of the tensile force of carbon fiber cloth pasted on the side and the corresponding correction factor η f of the force arm, and analyzes it by fitting a quadratic trend function with the ratio of CFRP pasting height to beam height ( h f / h ). Based on this, the calculation methods for the bending capacity of carbon fiber cloth pasted on the bottom surface according to the “Code” and the bending capacity of carbon fiber cloth pasted on the bottom surface according to the quadratic trend function are proposed. Research has shown that using CFRP to reinforce reinforced concrete beams on the side can effectively improve the flexural bearing capacity. After comparative analysis, the calculation results of three calculation methods are in good agreement with the experimental values; The correction coefficient η f increases with the increase of the ratio of the bonding height to the beam height ( h f / h ). When the ratio of the bonding height to the beam height ( h f / h ) exceeds 0.25, the value of the correction coefficient η f increases significantly; Especially when the ratio of the pasting height to the beam height ( h f / h ) exceeds 0.5, it is recommended to calculate the flexural bearing capacity of carbon fiber cloth pasted on the bottom surface according to the proposed quadratic trend function for η f ; At the same time, it is recommended to consider the reduction of the cross-sectional area of carbon fiber cloth as compensation when determining the flexural bearing capacity of reinforced concrete beams with carbon fiber cloth pasted on the side according to the calculation of the beam bottom. In order to reduce errors, the utilization coefficient of ψ f is no longer limited. Theoretical analysis shows that there are critical values for the bonding height and thickness of carbon fiber cloth used for reinforcement. When these exceed the critical value, the effect on enhancing load-bearing capacity becomes insignificant or even declines.

Engineering single-chain variable fragments to identify pathogenic antibodies in heparin-induced thrombocytopenia

Blood Anna-Lise Bissola, Donald M. Arnold, Yi Zhang et al. Jul 02, 2026 DOI: 10.1182/blood.2025031696

Abstract Heparin-induced thrombocytopenia (HIT) is characterized by the production of pathogenic antibodies that bind to complexes of platelet factor 4 (PF4) and heparin, causing platelet activation and a hypercoagulable state. A significant proportion of heparin-treated patients develop nonpathogenic anti-PF4/heparin antibodies that do not activate platelets but interfere with routine screening tests causing frequent false-positive results. We recently showed that pathogenic HIT antibodies are monoclonal and bind to an overlapping PF4 binding site, which could be exploited to identify clinically significant antibodies in patients. This study aimed to develop epitope-specific inhibitors based on the HIT-like murine monoclonal antibody (KKO) that recognizes a binding site overlapping with patient-derived pathogenic HIT antibodies on PF4. We developed a wild-type single-chain variable fragment (scFv) derived from KKO and performed site-directed mutagenesis to create a library of mutant anti-PF4/heparin scFv sequences. Five candidate scFvs were selected based on sequence enrichment after phage biopanning. We confirmed the high affinity and specific binding of these scFv fragments to PF4/heparin complexes using enzyme immunoassays (EIAs) and biolayer interferometry and demonstrated that KKO and all scFvs bind to an overlapping heparin-dependent site on PF4 by epitope mapping. Using patient sera, we demonstrated that our scFv candidates selectively inhibit the binding of pathogenic anti-PF4/heparin HIT antibodies and prevented platelet activation of some samples in the serotonin release assay. Importantly, the binding of nonpathogenic antibodies to PF4/heparin was unperturbed. These findings support the use of scFvs targeting a shared pathogenic region on PF4 to improve the diagnostic accuracy of anti-PF4/heparin EIAs for HIT.

Motor ability-aware adaptive pose estimation with hierarchical uncertainty modeling and cross-ability learning

Scientific Reports Qian Wang, Quan Zhou, Jinshan Yang et al. Jul 02, 2026 DOI: 10.1038/s41598-026-55466-0

Abstract The current human pose estimation systems suffer from large decreases in accuracy as they are applied to people of different motor abilities. Current approaches to human pose estimation rely heavily upon a standardized anatomy that does not allow for the quantification of uncertainty. In this paper we propose an extensive framework for the human pose estimation problem that is composed of three sub-modules. The first module, called MADSRNet, dynamically alters the structure of skeletons to represent varying motor abilities by utilizing gated fusion and dynamic graph construction. The second module, called HUGPose, utilizes heteroscedastic regression to provide hierarchical uncertainty estimates at the joints, limbs, and body level. Finally, the third module, called CADCL, utilizes both contrastive learning and domain adversarial training to enable the transfer of knowledge across different motor abilities. We evaluate our proposed framework on the DiverseMotor-PE dataset and obtain state-of-the-art results (41.2 mm MPJPE), which represents a 14.7% improvement compared to the best baseline (ViTPose). The difference in mean per-level MPJPE for typical individuals and those with severe motor impairments is reduced from 12.1 mm to 10.3 mm. The expected calibration error of the uncertainty estimates is 1.58%. The motor ability aware design of our framework is able to make accurate predictions for humans regardless of their motor ability. This work contributes to the development of inclusive human pose estimation systems and promotes equitable access to healthcare and assistive technologies.

CDIN1-Codanin-1 complex defective in congenital dyserythropoietic anaemia type I is an RNA nuclease

Nature Communications Sanja Brolih, Hafiz Saqib Ali, Caroline Scott et al. Jul 02, 2026 DOI: 10.1038/s41467-026-74766-7

Abstract Congenital Dyserythropoietic Anaemia type I (CDA-I) is a rare inherited disorder of erythropoiesis, in which erythroid cells display a unique nuclear phenotype referred to as ‘spongy’ heterochromatin. The molecular basis of CDA-I remains unknown, with most cases of CDA-I caused by mutations in CDAN1 , encoding Codanin-1, or CDIN1 , encoding for Codanin-1-interacting nuclease 1 (CDIN1). To date, very little is known about the function of CDA-I disease proteins and the mechanism by which their associated mutations cause disease. Here, we demonstrate that endogenous CDIN1 interacts with Codanin-1, to form a stable complex. Structural and functional analysis of this complex reveals that the CDIN1-Codanin-1 complex is an RNA nuclease. We shed light on the key mechanistic features of the complex using biochemical and biophysical approaches, complemented by all-atom molecular dynamics (MD) structural simulations. We identify various functional consequences of founder patient mutations on the RNA nuclease activity of CDIN1, providing a framework for understanding the pathophysiology and developing therapeutic strategies for CDA-I.